Status:
UNKNOWN
Mhealth and Teach-Back Effectiveness In 30-Day Readmissions Reduction
Lead Sponsor:
Health Services Academy, Islamabad, Pakistan
Conditions:
Readmission
mHealth
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
The Study is a feasibility randomized controlled trial aiming to assess the feasibility of mHealth (voice call and SMS) and teach-back interventions on reducing the 30 days readmission rate in the pat...
Detailed Description
Interventional Description of intervention(s) / exposure The study will comprise of three phases Phase I = Preparation Phase II= Implementation and monitoring Phase III = Evaluation Phase I (Preparati...
Eligibility Criteria
Inclusion
- Adult patients \> 30 years of age
- Incident adult cases with index admission in PMNHP
- Ischemic Heart disease, Myocardial Infarction, Hypertension, Diabetes Mellitus, Bronchial Asthma
- Patients with a valid mobile number
- Able to read the SMS in Urdu
Exclusion
- Serious mental illness such as schizophrenia,
- Are unable to use a telephone
- Are cognitively impaired during hospitalization as diagnosed by the consultant
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04738669
Start Date
March 1 2020
End Date
June 1 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alkhidmat AlRazi Hospital
Islamabad, Punjab Province, Pakistan, 46000